Professor, David Geffen School of Medicine at UCLA
Radiation Oncology
Dr. Joanne B. Weidhaas, MD
|
|
Give Review
Joanne Weidhaas practices Radiation Oncology. She went to Tufts University School of Medicine. Tufts University School of Medicine is ranked 49/52 in Research/PrimaryCare. She received awards:"Yale Cancer Center Award, “Most Influential Paper in the Field"", "Michael Fry Research Award", "Recognition of Clinical Excellence Award", "Howard Hughes Medical Institute Award for Genetics in Medicine", "ASTRO Travel Grant Recipient", "Student Travel Award", "Roentgen Resident/Fellow Research Award" and "Gordon Research Conference Young Investigator Award". Joanne Weidhaas is also published. She has 52 publications published. The lastest publication: "miR-34 activity is modulated through 5'-end phosphorylation in response to DNA damage.'
Publications
- A 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
- Targeted resequencing of the microRNAome and 3'UTRome reveals functional germline DNA variants with altered prevalence in epithelial ovarian cancer.
- Radiation therapy oncology group gynecologic oncology working group: comprehensive results.
- Extensive sequence variation in the 3' untranslated region of the KRAS gene in lung and ovarian cancer cases.
- Current Status and Recommendations for the Future of Research, Teaching, and Testing in the Biological Sciences of Radiation Oncology: Report of the American Society f...
- SNPing cancer in the bud: MicroRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer.
- KRAS-LCS6 Genotype as a Prognostic Marker in Early-Stage CRC-Response.
- A Prospective, Multicenter Study of Complementary/Alternative Medicine (CAM) Utilization During Definitive Radiation for Breast Cancer.
- KRAS alleles: The LCS6 3'UTR variant and KRAS coding sequence mutations in the NCI-60 panel.
- Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells.
- KRAS rs61764370 in Epithelial Ovarian Cancer-Letter.
- A let-7 microRNA SNP in the KRAS 3'UTR is prognostic in early-stage colorectal cancer.
- MicroRNA signatures differentiate melanoma subtypes.
- The holman research pathway in radiation oncology.
- Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice.
- miRNAs in the spotlight: Making 'silent' mutations speak up.
- Rare BRCA1 haplotypes including 3'UTR SNPs associated with breast cancer risk.
- MicroRNA signatures differentiate uterine cancer tumor subtypes.
- A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk.
- Prevalence of the variant allele rs61764370 T>G in the 3'UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer families.
- Changes in gene expression predicting local control in cervical cancer: results from Radiation Therapy Oncology Group 0128.
- MicroRNA in cancer prognosis.
- A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk.
- Postmastectomy radiation therapy for lymph node-negative, locally advanced breast cancer after modified radical mastectomy: analysis of the NCI Surveillance, Epidemiol...
- The let-7 microRNA reduces tumor growth in mouse models of lung cancer.
- MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy.
- A conserved RAS/mitogen-activated protein kinase pathway regulates DNA damage-induced cell death postirradiation in Radelegans.
- The KRAS-Variant and miRNA Expression in RTOG Endometrial Cancer Clinical Trials 9708 and 9905.
- MicroRNA binding-site polymorphisms as potential biomarkers of cancer risk.
- The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells.
- A Variant in a MicroRNA complementary site in the 3'' UTR of the KIT oncogene increases risk of acral melanoma.
- MicroRNA binding site polymorphisms as biomarkers of cancer risk.
- MicroRNAs: tools for cancer diagnostics.
- MicroRNAs as potential cancer therapeutics.
- Regression of murine lung tumors by the let-7 microRNA.
- miRNA modulation of the cellular stress response.
- Relationship between retroviral DNA integration and gene expression.
- MicroRNAs as a potential magic bullet in cancer.
- A Caenorhabditis elegans tissue model of radiation-induced reproductive cell death.
- Cancer microRNAs: from subtype profiling to predictors of response to therapy.
- Common variants at 19p13 are associated with susceptibility to ovarian cancer.
- Genetic and epigenetic association studies suggest a role of microRNA biogenesis gene exportin-5 (XPO5) in breast tumorigenesis.
- Characteristics and Outcomes of Breast Cancer in Women With and Without a History of Radiation for Hodgkin's Lymphoma: A Multi-Institutional, Matched Cohort Study.
- A 3''-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis.
- Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer.
- Breast sentinel lymph node dissection before preoperative chemotherapy.
- Using microRNAs to understand cancer biology.
- microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis.
- Preoperative chemotherapy decreases the need for re-excision of breast cancers between 2 and 4 cm diameter.
- A germline mutation in the BRCA1 3'UTR predicts Stage IV breast cancer.
- miR-34 activity is modulated through 5'-end phosphorylation in response to DNA damage.
Schools
Tufts University
Caritas Carney Hospital
Mem Sloan Kettering Cancer Center
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- Yale Cancer Center Award, “Most Influential Paper in the Field"
- Michael Fry Research Award
- Recognition of Clinical Excellence Award
- Howard Hughes Medical Institute Award for Genetics in Medicine
- ASTRO Travel Grant Recipient
- Student Travel Award
- Roentgen Resident/Fellow Research Award
- Gordon Research Conference Young Investigator Award
Education
-
Stanford Graduate School of Business -
Memorial Sloan-Kettering Cancer Center -
Tufts University School of Medicine -
Yale University
Hospital
-
Yale-New Haven Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Peter M. Glazer, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Joseph Contessa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lynn D. Wilson, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Christin A. Knowlton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen L. Shiao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Meena S. Moran, MD |
|
|
Dr. Henry S. Park, MD |
|
|
Dr. Trevor Bledsoe, MD |
|
|
Dr. Sanjay Aneja, MD |
|
|
Dr. Grace A. Dixon, MD |